Nidal Yunis
Cardiovascular Disease · Dothan, ALNPI 1952360406
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $667 and has fallen 95.0% since, to $33 in 2023. That places this record below the midpoint for cardiovascular disease clinicians in AL, where the typical reported total is $2,733.
Across 67 payments — averaging $17.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$190
- Medtronic$156
- Novartis$116
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$114
- Philips North America LLC$104
- Pfizer$86
- plus $414 from 15 others
What the payments were for
- Food & beverage$1,15898%
- Education$222%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 14 | $190 |
| Medtronic(2 entities) | 4 | $156 |
| Novartis | 8 | $116 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $114 |
| Philips North America LLC | 2 | $104 |
| Pfizer | 6 | $86 |
| Lundbeck LLC | 4 | $65 |
| Boston Scientific | 3 | $58 |
| AstraZeneca | 4 | $54 |
| Bayer | 2 | $36 |
| Cardiovascular Systems Inc. | 2 | $36 |
| E.r. Squibb & Sons, L.L.C. | 2 | $33 |
| Johnson & Johnson | 1 | $18 |
| Abiomed | 1 | $16 |
| Atricure, Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $15 |
| Chiesi USA, Inc. | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Vital Connect, Inc | 1 | $11 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,179 in reported general payments places this provider in the 35th percentile of 292 cardiovascular disease providers in Alabama.
Other cardiovascular disease in Dothan
- Anjula ChibDothan$27K
- Andreas MuenchDothan$18K
- Darius AliabadiDothan$11K
- Dennis ThomasMobile$894K
- David FienoAlabaster$421K
- Vikram AroraBirmingham$271K
- Jason ThompsonBirmingham$248K
- Michael WilenskyBirmingham$241K
- Mustafa AhmedBirmingham$218K
- Frederick GaskinBirmingham$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.